Coronavirus Vaccine India Live Updates: Ahead of the coronavirus vaccine rollout, a second dry run will take place on January 8, Friday, in all districts of the country, news agency ANI reported. Meanwhile, the Ministry of Health and Family Welfare today said it will send a high-level team to Kerala for supporting the state amid rising coronavirus cases. Kerala recorded a total of 35,038 new cases during the last seven days in Kerala.
A total of 71 people have tested positive for the new UK variant of SARS-CoV-2 in India so far, the Union Health Ministry said today. The new coronavirus variant found in the UK is said to 70 per cent more infectious than the first one. India’s COVID-19 caseload, meanwhile, rose to 1,03,74,932 with 18,088 infections being reported in a day, while the recoveries are nearing one crore. The death toll increased to 1,50,114 with 264 people succumbing to the disease in a span of 24 hours. The active caseload remained below 3 lakh for the 16th consecutive day.
Days after two vaccines — Covaxin developed by Bharat Biotech with Indian Council of Medical Research (ICMR), and Covishield, a variant of Oxford AstraZeneca’s AZD1222 manufactured under licence by the Serum Institute of India — got regulatory approval, the Union Health Ministry said that they are prepared to roll out the mass immunisation programme within 10 days. The decision on rolling out India’s biggest adult vaccination drive will, however, be taken by the central government, it said.
Meanwhile, minutes from the expert committee’s meetings show how they changed their decision within 24 hours and recommended Bharat Biotech’s Covid-19 vaccine candidate for approval without proof of its efficacy in humans.
In other news, the World Health Organization’s director-general complained about China’s delay in granting visas to an incoming WHO team seeking to investigate Covid-19’s origins. In Europe, one out of 50 people has coronavirus in England now, the British government said. Germany extended its lockdown and tightened restrictions, while Italy strengthened some measures to counter the risk of a resurgence.